1.Effects of exercise rehabilitation nursing combined with pain management on preventing deep vein thrombosis and postoperative pain in aged patients with joint replacement
Liujuan ZHANG ; Chunyan XU ; Feifei WANG ; Ji SHEN ; Qian ZHANG
Chinese Journal of Modern Nursing 2022;28(25):3465-3469
Objective:To explore the effects of exercise rehabilitation nursing combined with pain management on preventing deep vein thrombosis (DVT) and postoperative pain in aged patients with joint replacement.Methods:Totally 110 patients undergoing joint replacement at Zhejiang Provincial People's Hospital from January 2018 to July 2021 were selected by convenience sampling and divided into an observational group and a control group, with 55 patients in each group. Patients in the control group received routine nursing, while patients in the observation group underwent exercise rehabilitation nursing combined with pain management. The hemorheological indexes, Visual Analog Scores (VAS) , and the incidence of DVT before and after nursing intervention were compared between the two groups.Results:Before nursing intervention, there was no significant difference in hemorheological indexes and VAS scores between the two groups ( P>0.05) . After nursing intervention, the whole blood mid-shear viscosity, low-shear viscosity, plasma viscosity, platelet aggregation rate, VAS score, and incidence of DVT in the observation group were lower than those in the control group, and the differences were statistically significant ( P<0.05) . Conclusions:Exercise rehabilitation nursing combined with pain management can improve the hemorheological indexes of aged patients after joint replacement, effectively relieve their postoperative pain, and reduce the incidence of postoperative DVT.
2.Clinical features and prognosis of HBV-related acute-on-chronic liver failure in pregnancy
Liujuan JI ; Xue MEI ; Wei YUAN ; Ying ZOU ; Yu LIU ; Jiefei WANG ; Zhiping QIAN
Journal of Clinical Hepatology 2022;38(4):788-792
Objective To investigate the clinical features and prognosis of pregnant women with HBV-related acute-on-chronic liver failure (HBV-ACLF). Methods A retrospective analysis was performed for the clinical data of 26 pregnant women with HBV-ACLF who were admitted to Shanghai Public Health Clinical Center from June 2008 to July 2020, including age, gestational weeks at disease onset, parity, initial symptoms, complications on admission, laboratory markers [white blood cell count, hemoglobin, platelet count, alanine aminotransferase, total bilirubin (TBil), albumin, serum creatinine, Model for End-Stage Liver Disease (MELD) score, HBsAg, and HBV DNA], abdominal ultrasound, mode of delivery, fetus conditions, treatment measures, and prognosis. The t -test was used for comparison of normally distributed continuous data between two groups, and the Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test and the Fisher's exact test were used for comparison of categorical data between two groups. Results Among the 26 patients, 8 died within 28 days after disease onset, and the mortality rate reached 30.8%. There were 22 multiparous patients, accounting for 84.6%, and HBV-ACLF often occurred in the third trimester of pregnancy (20/26, 76.9%), with a mean gestational age of 30.9±5.8 weeks. HBV-ACLF often had atypical clinical manifestations, and initial symptoms included weakness, poor appetite (21/26, 80.8%), and yellow urine (19/26, 73.1%). Compared with the survival group, the death group had significantly higher levels of TBil ( Z =-2.056, P =0.041), prothrombin time ( Z =-2.362, P =0.016), international normalized ratio ( Z =-2.528, P =0.009), and MELD score ( Z =-2.223, P =0.026), a significantly longer time from initial symptom to diagnosis ( Z =-2.468, P =0.021), significantly higher HBV DNA level ( χ 2 =7.571, P =0.021), degree of hepatic encephalopathy ( χ 2 =24.775, P < 0.001), and incidence rate of complications ( χ 2 =5.951, P =0.042), and significantly lower levels of fibrinogen ( Z =-2.667, P =0.006) and prothrombin time activity ( Z =-2.365, P =0.016). Conclusion HBV-ACLF is a serious complication in the third trimester of pregnancy and is often observed in multiparous patients, with an extremely high short-term mortality. It often has atypical clinical manifestations in the early stage, and high MELD score, high viral load, and complications often indicate a poor prognosis.